In summary, our study emphasizes the essential role of the lnc-ZEB2-19/TRA2A/RSPH14 signaling axis in the suppression of HCC metastasis and lenvatinib resistance. The gene discussed is RSPH14; the disease is hepatocellular carcinoma.